AZD6738 for Patients With Progressive MDS or CMML
AZD6738 for Patients With Progressive MDS or CMML
Active, not recruiting · NCT03770429 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AZD6738 for Patients With Progressive MDS or CMML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, neoplasm | Active, not recruiting | Phase 1 | 2026-09-30 | NCT03770429 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Massachusetts General Hospital | 758 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BIDMC | Boston | United States | 6 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Massachusetts General Hospital Cancer Center | Boston | United States | 15 |
| Washington University | St Louis | United States | 182 |